, Novartis’ Million Dollar Gene Therapy Drug Sales Boost Earnings
Novartis, the Swiss drugmaker, in its fourth-quarter earnings reported a jump of 9 per cent in sales, raking in $12.4 billion and the company …
, What Novartis’ Potential Acquisition of The Medicines Company Means for the Industry Leader
In the recent deal, Novartis on 24th November 2019 announced that it was going to buy The Medicines Company for $9.7 billion. The pharmaceutical …
, Sandoz launches the 1st version of multiple sclerosis drugs in US
Novartis International AG/ Sandoz reports US launch of Glatopa(TM), the first generic contender to Copaxone(R) 20mg. Processed and transmitted by NASDAQ OMX Corporate Solutions. …
